• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.2070 +0.0360 (+21.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,565,222
Open 0.1800
Bid (Size) 0.1900 (27,900)
Ask (Size) 0.1987 (800)
Prev. Close 0.1710
Today's Range 0.1770 - 0.2105
52wk Range 0.1151 - 2.710
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stay updated with the stocks that are on the move in today's after-hours session. ↗
January 02, 2026
Via Chartmill
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
December 24, 2025
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill

Performance

YTD
N/A
N/A
1 Month
-46.0%
-46.0%
3 Month
-64.0%
-64.0%
6 Month
-58.8%
-58.8%
1 Year
-92.2%
-92.2%

More News

Read More
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
December 23, 2025
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
December 23, 2025
Via Chartmill
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
December 18, 2025
Via TheNewswire.com
GeoVax Addresses Identification of New Mpox Variant
December 11, 2025
Via TheNewswire.com
Topics Supply Chain
News headline image
Monday's after hours session: top gainers and losers ↗
December 22, 2025
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
December 22, 2025
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
December 19, 2025
Via Chartmill
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
December 10, 2025
Via TheNewswire.com
News headline image
Which stocks are moving on Friday? ↗
December 19, 2025
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
December 19, 2025
Via Chartmill
News headline image
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
December 19, 2025
Via NewMediaWire
Topics Regulatory Compliance
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
December 19, 2025
Via TheNewswire.com
Topics Regulatory Compliance
News headline image
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
December 18, 2025
Via NewMediaWire
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
December 18, 2025
Via TheNewswire.com
News headline image
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
December 18, 2025
Via NewMediaWire
News headline image
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
December 17, 2025
Via NewMediaWire
Topics Supply Chain
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
December 17, 2025
Via TheNewswire.com
Topics Supply Chain
News headline image
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
December 16, 2025
Via NewMediaWire
Topics Intellectual Property
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
December 16, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
December 15, 2025
Via NewMediaWire
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
December 15, 2025
Via TheNewswire.com
News headline image
GeoVax Addresses Identification of New Mpox Variant
December 11, 2025
Via NewMediaWire
Topics Supply Chain
News headline image
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
December 10, 2025
Via NewMediaWire

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 0.2070
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 449.67K
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 450K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap